The Attention-Deficit/Hyperactivity Disorder (ADHD), a neurodevelopmental disorder that affects a person’s ability to focus, control impulses, and regulate their activity levels, is in the news as the pharma primary Glenmark Recalls ADHD Medication in the US Due to Labeling Issues.
Glenmark Pharmaceuticals has voluntarily recalled several bottles of its ADHD medication in the United States. The recall follows concerns over incorrect labeling that could lead to dosing errors. The U.S. Food and Drug Administration (FDA) has classified this as a Class II recall, indicating a potential patient risk if misused medication.
Why is Glenmark Recalling Medication?
The recall involves bottles of Guanfacine Extended-Release Tablets, a medication used to manage Attention-Deficit/Hyperactivity Disorder (ADHD). The issue was identified when reports indicated that the bottles contained incorrect dosage strength. This labeling error could lead to patients taking an overdose or an insufficient dose, impacting their treatment.
Incorrect dosages of Guanfacine can cause low blood pressure, dizziness, sedation, and withdrawal symptoms if stopped suddenly. The company has advised patients and healthcare providers to check their medication bottles and return affected products.
Understanding ADHD
ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects children and adults, interfering with daily life, academic performance, and social relationships.
What is an ADHD Person Like?
People with ADHD often struggle with Maintaining focus on tasks, Following instructions or completing work, Managing time effectively, Controlling impulses and emotions, and Staying organized.
ADHD presents differently in each individual, with some being more inattentive and others displaying hyperactivity.
Do I Have ADHD or Depression?
ADHD and depression share symptoms like difficulty concentrating and low motivation. However, it is linked to brain function and executive dysfunction, while depression is associated with persistent sadness, hopelessness, and a lack of interest in activities. A professional assessment can determine the correct diagnosis.
Adult ADHD Behaviors
Adults with this disorder may experience Chronic procrastination, impulsivity in decision-making, Struggles with time management, Frequent mood swings, Difficulty maintaining relationships, and Sensitivity to criticism.
Can ADHD Be Overcome?
ADHD is a lifelong condition, but behavioral therapy, medication, and structured routines help manage symptoms effectively. Many individuals lead successful lives with proper treatment.
Do People with ADHD Talk a Lot?
Yes, many individuals with this disorder display excessive talking, interjecting conversations, changing topics quickly, or struggling to wait for their turn to speak. This is due to impulsivity and difficulty regulating thoughts.
Famous People with ADHD
Several public figures have ADHD, including Michael Phelps (Olympic swimmer), Justin Timberlake (Singer/Actor), Richard Branson (Entrepreneur), and Simone Biles (Olympic gymnast); their success highlights that ADHD can be managed with the proper support.
Is ADHD Curable?
ADHD is not curable, but it is manageable. Medication, cognitive-behavioral therapy (CBT), and lifestyle adjustments help control symptoms.
What Do ADHD People Enjoy?
People with ADHD thrive in creative, high-energy environments. They enjoy Fast-paced activities like sports, Artistic pursuits (music, painting, writing) , Hands-on projects (building, designing), and Socially engaging careers.
Do I Have ADHD, or Am I Just Lazy?
ADHD is not laziness. Individuals with ADHD struggle with executive dysfunction, making it difficult to initiate and complete tasks despite the intention to do so.
What Does ADHD Look Like in Girls?
ADHD in girls is often underdiagnosed because symptoms present differently. They may exhibit Daydreaming instead of hyperactivity, Social anxiety and perfectionism, Emotional sensitivity, Struggles with organization, Countries with High ADHD Cases
ADHD is prevalent in the United States, Canada, Australia, the United Kingdom, Germany, and Brazil. These countries have higher diagnosis rates due to increased awareness and access to mental health services.
